dc.contributor.author | Eskandani, M | |
dc.contributor.author | Dadizadeh, E | |
dc.contributor.author | Hamishehkar, H | |
dc.contributor.author | Nazemiyeh, H | |
dc.contributor.author | Barar, J | |
dc.date.accessioned | 2018-08-26T08:56:14Z | |
dc.date.available | 2018-08-26T08:56:14Z | |
dc.date.issued | 2014 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54415 | |
dc.description.abstract | Introduction: Dorema glabrum (Apiaceae) is a rare and monocarpic species distributed in Transcaucasia and North West of Iran. We aimed to explore anticancer potency of bioactive compounds from the seeds of Dorma glabrum. Methods: Methanol extract was subjected to phytochemical investigation using normal phase Sep-pak and reversed-phase HPLC, and cytotoxic effect of isolated compounds on CAOV-4 cell line was evaluated. Furthermore, Annexin V/PI staining and comet assay were used to study genotoxicity of compounds. Results: Diglucosyl caffeoyl ester (1), Glucopyranosylcaffeic acid (2) and skimmin (3), were identified. MTT cytotoxicity assay showed growth inhibition of CAOV-4 cells due to treatment with compunds (1), (2) and (3) with an IC50 of 99.7, 87.3 and 70.03 ?g/ml at 48 h, respectively. Annexin V-FITC/PI staining showed occurrence of early/late apoptosis in the (1)-treated cells, while (2)-and (3)-treated cells necrosis/late apoptosis was dominant event. Single/double strands DNA breakages were observed by comet assay in all treatments. Conclusion: This work provides sufficient information about anti-cancer properties of the diglucosyl caffeoyl ester from the seeds of D. glabrum. أ¯?آ½ 2014 The Author(s). | |
dc.language.iso | English | |
dc.relation.ispartof | BioImpacts | |
dc.subject | antineoplastic agent | |
dc.subject | diglucosylcaffeoyl ester | |
dc.subject | Dorema glabrum extract | |
dc.subject | doxorubicin | |
dc.subject | glucopyranosylcaffeic acid | |
dc.subject | methanol | |
dc.subject | phenol derivative | |
dc.subject | plant extract | |
dc.subject | skimmin | |
dc.subject | unclassified drug | |
dc.subject | antineoplastic activity | |
dc.subject | Apiaceae | |
dc.subject | apoptosis | |
dc.subject | Article | |
dc.subject | cancer cell line | |
dc.subject | cancer inhibition | |
dc.subject | controlled study | |
dc.subject | Dorema glabrum | |
dc.subject | double stranded DNA break | |
dc.subject | drug cytotoxicity | |
dc.subject | drug identification | |
dc.subject | drug potency | |
dc.subject | drug structure | |
dc.subject | female | |
dc.subject | genotoxicity | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | IC50 | |
dc.subject | ovary adenocarcinoma | |
dc.subject | phytochemistry | |
dc.subject | plant seed | |
dc.subject | single stranded DNA break | |
dc.subject | Apiaceae | |
dc.subject | Dorema | |
dc.title | Geno/cytotoxicty and apoptotic properties of phenolic compounds from the seeds of Dorema glabrum Fisch. C.A | |
dc.type | Review | |
dc.citation.volume | 4 | |
dc.citation.issue | 4 | |
dc.citation.spage | 191 | |
dc.citation.epage | 198 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.15171/bi.2014.019 | |